Cargando…
Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients
BACKGROUND: Deregulation of the Wnt signaling pathway had a role in haematological malignancies. Previous studies reported that lymphoid enhancer factor 1 (LEF1) expression and serum Galectin-3 level could affect clinical parameters and outcome in acute myeloid leukemia patients, but as far as we kn...
Autores principales: | ElBaiomy, M. A., Aref, S., El Zaafarany, M., Atwa, Sara, Akl, Tamer, El-Beshbishi, Wafaa, El-Ashwah, Shaimaa, Ibrahim, L., El-Ghonemy, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935809/ https://www.ncbi.nlm.nih.gov/pubmed/31929803 http://dx.doi.org/10.1155/2019/2352919 |
Ejemplares similares
-
Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020) -
Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs
por: El-Ghonemy, Mohamed Sabry, et al.
Publicado: (2021) -
Short Dysfunctional Telomere Is Highly Predictive of Dismal Outcome in MDS but Not in AML Patients
por: Menshawy, Nadia El, et al.
Publicado: (2020) -
Prognostic Impact of IL17 A Gene Polymorphismson Egyptian Patients with Multiple Myeloma
por: Mortada, Metwaly Ibrahim, et al.
Publicado: (2023) -
TERT Genotype Polymorphism: A Glance of Change Egyptian MDS Outcomes
por: El Menshawy, Nadia, et al.
Publicado: (2021)